Evotec/Pfizer initiate Phase I trial of VR1 antagonist « Ion channel News

Evotec/Pfizer initiate Phase I trial of VR1 antagonist

Posted on August 1, 2008 by crimsoncanary

Evotec AG have announced the initiation of a Phase I clinical trial of a small molecule VR1 (vanilloid receptor 1) antagonist in collaboration with Pfizer

Filed under: Ion Channel | Tagged: antagonist, Evotec, Pfizer, phase I, TRPV1, Vanilloid, vanilloid 1

« Banner Pharmacaps soft gel Valproic acid approved by FDA Cleviprex approved in US »

Leave a Reply